Insulin Therapy of Nondiabetic Septic Patients Is Predicted by <i>para</i>-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine

<div>Chromatograms of a standard (STD), a serum (SE), and a urine sample of a septic patient (U).<i> p</i>-Tyr,<i> para</i>-tyrosine;<i> m</i>-Tyr,<i> meta</i>-tyrosine;<i> o</i>-Tyr,<i> ortho</i>-tyrosine; Phe, phenylalanine.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Insulin Therapy of Nondiabetic Septic Patients Is Predicted by <i>para</i>-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine 

Figure 1 | Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine 